Dermatitis atopic
Not yet recruitingSafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)
- Disease:Dermatitis atopic
- Substances:–
Spain- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Back to Spain2 clinical trials in Mieres, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on atopic dermatitis management are evaluating innovative therapeutic approaches for adolescents and adults with moderate to severe cases. These trials aim to assess new treatment options for patients who may benefit from systemic therapy.
The research examines the effectiveness and safety profile of emerging immunomodulatory treatments for eczema, potentially offering new hope for patients with persistent symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.